Cargando…

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma

Cholangiocarcinoma (CCA) is a highly heterogeneous and aggressive malignancy of the bile ducts with a poor prognosis and high mortality rate. Effective targeted therapy and accurate prognostic biomarkers are still lacking. Ferroptosis is a form of regulated cell death implicated in cancer progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sae-fung, Apiwit, Mutirangura, Apiwat, Jitkaew, Siriporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887182/ https://www.ncbi.nlm.nih.gov/pubmed/36733386 http://dx.doi.org/10.3389/fimmu.2022.1051273

Ejemplares similares

Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells
por: Lomphithak, Thanpisit, et al.
Publicado: (2023)

Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma
por: Lomphithak, Thanpisit, et al.
Publicado: (2020)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

Ferroptosis gene signature in cholangiocarcinoma
por: Cingaram, Pradeep Reddy
Publicado: (2022)

Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma: Ferroptosis-related gene model for ICC
por: Yao, Xinfei, et al.
Publicado: (2022)

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma
por: Ma, Xiaochen, et al.
Publicado: (2022)

Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
por: Lomphithak, Thanpisit, et al.
Publicado: (2021)

Matrigel induces L-plastin expression and promotes L-plastin-dependent invasion in human cholangiocarcinoma cells
por: CHAIJAN, SUTHIDARAK, et al.
Publicado: (2014)

Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
por: Wu, Man-Ning, et al.
Publicado: (2023)

Patterns and Possible Roles of LINE-1 Methylation Changes in Smoke-Exposed Epithelia
por: Wangsri, Siriporn, et al.
Publicado: (2012)

Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis
por: Akara-amornthum, Perawatt, et al.
Publicado: (2020)

Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer
por: Liu, Qin, et al.
Publicado: (2021)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021)

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2022)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
por: Zhang, Heng-Chun, et al.
Publicado: (2022)

Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential
por: XL, Lei, et al.
Publicado: (2022)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma
por: Fan, Yang, et al.
Publicado: (2022)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2022)

Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
por: Yang, Mingyu, et al.
Publicado: (2023)

Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy
por: Zhao, Ting, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
por: Zhang, Zhao-Cong, et al.
Publicado: (2021)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis
por: He, Xu, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
por: Guo, Wenna, et al.
Publicado: (2022)

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
por: Xie, Hongjun, et al.
Publicado: (2022)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Xu, Yuhao, et al.
Publicado: (2022)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
por: Wang, Yuanyong, et al.
Publicado: (2022)

Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma
por: Da, Qingen, et al.
Publicado: (2022)

Exploration and Validation of Potential Biomarkers and Therapeutic Targets in Ferroptosis of Asthma
por: Xing, Yanqing, et al.
Publicado: (2023)

Ferroptosis and musculoskeletal diseases: “Iron Maiden” cell death may be a promising therapeutic target
por: Zhang, Yili, et al.
Publicado: (2022)

Ferroptosis as an emerging target in rheumatoid arthritis
por: Zhao, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40o6d9oe31vu2jegdg2qtj4kvj